| Patient | John F. Kennedy |
|---|---|
| Date of birth | 1917-05-29 |
| Identifiers | MRN HR-ML023-SYN-TD; SSN (made up) 000-23-5408 |
| Document date | 1948-04-20 |
| Author | Harlan Prescott, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-week review after starting levothyroxine. [S]
Mr. Kennedy returns six weeks after starting levothyroxine 50 mcg, which he takes each morning before breakfast. The morning slowness and feeling cold have gone, and he has no palpitations, tremor or sweating. He takes hydrocortisone 10, 5 and 5 mg and fludrocortisone 0.1 mg without missed doses and has had no illness. He has finished his course of physical therapy and keeps up the home program; he swims three or four times a week and wears the brace only on long journeys. He rarely needs acetaminophen. [S]
| Element | Detail |
|---|---|
| Levothyroxine | 50 mcg daily for six weeks; taken correctly |
| Symptoms | No slowness or cold; no palpitations or tremor |
| Back | Physical therapy finished; home program and swimming; Oswestry 18% |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good; weight up 1.6 kg |
| Cardiovascular | Negative | No palpitations or lightheadedness |
| Endocrine | Negative | No cold or heat intolerance, tremor, or sweating |
| Musculoskeletal | Positive | Mild back stiffness after long sitting |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrocortisone 10 mg oral tablet, two tablets (20 mg) on waking and one tablet (10 mg) at 2 pm, 30 mg a day (started in hospital) | Two tablets on waking and one tablet at 2 pm | Oral route | 1947-10-06 to 1948-01-26 | completed | S |
| Fludrocortisone 0.1 mg oral tablet, half a tablet (0.05 mg) by mouth once daily (started in hospital) | Half a tablet by mouth once daily | Oral route | 1947-10-06 to 1948-01-26 | completed | S |
| Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking | One tablet by mouth on waking | Oral route | 1948-01-26 | active | S |
| Hydrocortisone 5 mg oral tablet, one tablet by mouth at noon and one at 4 pm | One tablet at noon and one tablet at 4 pm (two doses a day) | Oral route | 1948-01-26 | active | S |
| Fludrocortisone 0.1 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily | Oral route | 1948-01-26 | active | S |
| Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 | Once, as needed for adrenal crisis; carry at all times | Intramuscular route | 1948-01-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times a day as needed for back pain | Two tablets up to three times a day as needed | Oral route | 1948-01-12 | active | S |
| Oseltamivir 75 mg oral capsule, one capsule by mouth twice daily for five days | One capsule twice daily for five days | Oral route | 1948-02-16 to 1948-02-20 | completed | S |
| Levothyroxine 50 mcg oral tablet, one tablet by mouth each morning on an empty stomach | One tablet each morning, 30 to 60 minutes before breakfast | Oral route | 1948-03-09 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1948-04-20 | Body height | 183 | cm | S |
| 1948-04-20 | Body weight | 70.6 | kg | S |
| 1948-04-20 | Body mass index (BMI) [Ratio] | 21.1 | kg/m2 | S |
| 1948-04-20 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1948-04-20 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1948-04-20 | Heart rate | 72 | /min | S |
| 1948-04-20 | Respiratory rate | 14 | /min | S |
| 1948-04-20 | Body temperature | 36.6 | Cel | S |
| 1948-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1948-04-20 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1948-04-20 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1948-04-20 | Thyrotropin [Units/volume] in Serum or Plasma | 3.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1948-04-20 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma | 1.2 | ng/dL | 0.8-1.8 ng/dL | Normal | S |
| 1948-04-20 | Oswestry disability index score ODI | 18 | {score} | S |
Vital signs recorded on 1948-04-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 70.6 kg; blood pressure 120/76 seated, pulse 72 and regular |
| Neck | Thyroid slightly firm, not enlarged |
| Neurological | No tremor |
| Back | Forward flexion to mid-shin; no tenderness |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Primary adrenal insufficiency (Addison's disease), diagnosed about three months ago during an adrenal crisis while traveling abroad, on hydrocortisone and fludrocortisone; synthetic modern episode linked to his documented 1869 diagnosis | active | confirmed | E27.1 | S — Synthetic modern coding of the documented diagnosis. |
| Chronic low back pain persisting after lumbar disc surgery; began after a football injury in college and worsened during wartime naval service; uses a corset brace; synthetic modern episode linked to his documented back history | active | confirmed | M96.1 | S — Synthetic modern coding of the documented back pain and operation. |
| Raised TSH with positive thyroid peroxidase antibodies and normal free T4 on screening for associated autoimmune disease; to be repeated before any treatment | resolved | confirmed | R94.6 | S — Synthetic screening finding. |
| Autoimmune (Hashimoto's) hypothyroidism, part of an autoimmune polyglandular syndrome with the adrenal insufficiency; started on levothyroxine | active | confirmed | E06.3 | S — Synthetic modern diagnosis anchored to his documented later hypothyroidism and its retrospective interpretation. |
| Influenza A with fever, managed at home with oseltamivir and doubled hydrocortisone under the sick-day rules; resolved | resolved | confirmed | J10.1 | S — Synthetic intercurrent illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Glucocorticoid dose: weight, energy, and signs of under- or over-replacement | Every visit | Completed today | Weight 70.6 kg; no signs of under- or over-replacement |
| Examination | Blood pressure lying and standing | Every visit | Deferred | Missed: only a seated blood pressure (120/76) was taken. No harm resulted: he had no lightheadedness, sodium and potassium were normal, and there was no postural drop when it was next measured at the preventive visit. Corrective action: lying and standing blood pressure added to the visit template for adrenal insufficiency |
| Laboratory | Mineralocorticoid: salt craving, edema, sodium and potassium | After any fludrocortisone change, then at least yearly | Completed today | Sodium 140, potassium 4.2 mmol/L |
| Laboratory | Plasma renin activity | After any fludrocortisone change, then at least yearly; aim for the upper normal range | Up to date | In range at the last check; next at the nine-month review |
| Self-management | Sick-day rules, emergency injection kit, steroid card, and medical ID | Every visit | Completed today | Rules reviewed; kit, card and medical ID with him |
| Laboratory | TSH and free T4 | 4 to 8 weeks after starting or changing levothyroxine, at 6 months once stable, then yearly | Completed today | Six weeks after starting levothyroxine: TSH 3.1 mIU/L, free T4 1.2 ng/dL |
| Medication safety | Levothyroxine: timing, interactions, and signs of over-replacement | At each thyroid review | Completed today | Taken correctly; no palpitations, tremor or weight loss |
| Laboratory | Other associated autoimmune disease: vitamin B12, A1c, and celiac serology | At diagnosis, then yearly or with symptoms | Up to date | Normal at intake; next yearly |
| Survey | Oswestry Disability Index | Each back pain review | Completed today | 18%, from 26% |
| Self-management | Exercise therapy, physical therapy, and brace use | Home program after the course of physical therapy | Completed today | Course finished; home program and swimming; brace for long journeys only |
| Medication safety | Analgesic use | Every visit | Completed today | Acetaminophen rarely; no NSAID or opioid |
Goal progress:
Guideline basis: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016); Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023); CMID: Clinical Monitoring Intelligence Database, hypothyroidism monograph (2026)
Follow-up: Preventive visit in four months. Nine-month review with electrolytes, renin and TSH. Endocrinology review at one year. Next scheduled visit 1948-08-17: periodic adult preventive visit. [S]